 |
|
|
 |
|
  |
|
 |
|
| 1) |
Y. Morita, O. Tsutsumi,
I. Hosoya, Y. Taketani, Y. Oka and T. Kato: Expression
and possible function of glucose transporter protein
GLUT1 during preimplantation mouse development from
oocytes to blastocysts. Biochemical Biophysical
Research Communication, 188: 8-5, 1992. |
| 2) |
Y. Morita, O. Tsutsumi,
Y. Oka and Y. Taketani: Glucose transporter GLUT1
mRNA expression in the ontogeny of glucose incorporation
in mouse preimplantation embryos. Biochemical Biophysical
Research Communication, 199: 1525-1531, 1994. |
| 3) |
S. Ishimaru, S. Izaki,
K. Kitamura and Y. Morita: Neonatal lupus erythematosus:
Dissolution of atrioventricular block after administration
of corticosteroid to the pregnant mother. Dermatology,
189: 92-94, 1994. |
| 4) |
O. Tsutsumi, Y. Morita,
I. Hosoya, T. Ayabe, T. Yano and Y. Taketani: Delayed
expression of hexokinase and glucose transporter
causes decreased glucose incorporation in mouse
embryos developed in vitro. in Perspectives on Assisted
Reproduction Eds. T.Mori, T Aono, T Tominaga and
M. Hiroi. Ares-Serono Symposia Series, Frontiers
in Endocrinology, Vol.4, 143-149, 1994. |
| 5) |
Y. Morita, O. Tsutsumi,
Y. Oka, H. Katagiri and Y. Taketani: Application
of reverse transcription-polymerase chain reaction
to study glucose transporter protein GLUT1 expression
in preimplantation mouse embryos. Journal of Mammalian
Ova Reserch, 11: 1-7. 1994. |
| 6) |
Y. Morita, O. Tsutsumi
and Y. Taketani: In vitro treatment of embryos with
epidermal growth factor improves viability and increases
the implantation rate of blastocysts transferred
to recipient mice. American Journal of Obstetrics
and Gynecology, 171: 406-409, 1994. |
| 7) |
M. Takami, O. Tsutsumi,
T. Ayabe, T. Takami, Y. Morita, H. Sakamoto, Y.
Taketani and K. Satoh: Hexokinase is a key enzyme
of glucose metabolism expressed during preimplantation
mouse development. Journal of Mammalian Ova Reserch,
12: 41-46, 1995. |
| 8) |
O. Tsutsumi, Y. Morita,
I. Hosoya, T. Ayabe, T. Yano and T. Taketani: Glucose
incorporation in mouse embryos based on hexokinase
and GLUT1 expression can be a measure of embryo
viability. in Biology of Pregnancy. Eds. T.Nakayama
and T. Makino. 97-106, 1995. |
| 9) |
Y. Taketani, M. Sadatsuki,
Y. Morita, T. Fujiwara, N. Hayashi, T. Yano, and
O. Tsutsumi: Activin A as a possible intraovarian
regulator. in New Achievements in Research of Ovarian
Function. Eds. S.Fujimoto, J.F.Straus, _、A.J.W.
Hsueh and T. Tanaka. Ares-Serono Symposia Series,
Frontier in Endocrinology, Vol.13, 147-152, 1995. |
| 10) |
Y. Morita, O. Tsutsumi
and Y. Taketani: Successful treatment of catamenial
pneumothorax with danazol. International Journal
of Obstetrics and Gynecology, 51: 263-264, 1995. |
| 11) |
Y. Morita, S. Hikage
and M. Ogino: Adenoid cystic carcinoma of Bartholin's
gland. International Journal of Obstetrics and Gynecology,
54: 279-280, 1996. |
| 12) |
Y. Morita, O. Tsutsumi,
K. Kuramochi, M. Momoeda, H. Yoshikawa and Y. Taketani:
Successful laparoscopic management of a primary
abdominal pregnancy. Human Reproduction, 11: 2546-2547,
1996. |
| 13) |
H. Uechi, O. Tsutsumi,
Y. Morita and Y. Taketani. Cryopreservation of mouse
embryos affects later embryonic development possibly
through reduced expression of the glucose transporter
GLUT1. Molecular Reproduction and Development, 48:
496-500, 1997. |
| 14) |
Y. Morita, O. Tsutsumi
and Y. Taketani: Successful hormonal treatment of
pulmonary endometriosis: a case report. International
Journal of Obstetrics and Gynecology, 59: 61-63,
1997. |
| 15) |
Y. Morita, O. Tsutsumi,
M. Momoeda and Y. Taketani: Cornual pregnancy successfully
treated laparoscopically with fibrin glue hemostasis.
Obstetrics and Gynecology, 90: 685-687, 1997. |
| 16) |
O. Tsutsumi, Y. Morita,
M. Momoeda, T. Yano and Y. Taketani: Factors influencing
embryo quality and viability in preimplantation
period-glucose incoporation can be a measureof embryo
quality and viability. in In vitro fertilization
and assisted reproduction Eds. V Gomel and PCK Leung.
by Monduzzi Editore Bologna, 653-659, 1997. |
| 17) |
T. Yano, N. Yano, N.
Matsumi, Y. Morita, O. Tsutsumi, A. V. Schally,
Y. Taketani: Effect of luteinizing hormone-releasing
hormone analogs on the rat ovarian follicle development.
Hormone Research, 48: 35-41, 1997. |
| 18) |
M. Momoeda, O. Tsutsumi,
Y. Morita, T. Igarashi, A. Suenaga, Y. Osuga, H.
Shiotsu, T. Yano, Y. Taketani: Differential effect
of exogenous human chorionic gonadotrophin on progesterone
production from normal or malfunctioning corpus
luteum. Human Reproduction, 13: 1907-1911, 1998. |
| 19) |
R.V. Carsia, R.G. Nagele,
Y. Morita, K. I. Tilly and J. L. Tilly: Models to
elucidate the regulation of adrenal cell death.
Endocrine Research, 24: 899-908, 1998. |
| 20) |
Y. Morita, T. M. Manganaro,
X.-J. Tao, S. Martimbeau, P. K. Donahoe, J. L. Tilly:
Requirement for phosphatidylinositol-3'-kinase in
cytokine-mediated germ cell survival during fetal
oogenesis in the mouse. Endocrinology, 140:941-949,
1999. |
| 21) |
Y. Morita, J. L. Tilly:
Segregation of retinoic acid effects on fetal ovarian
germ cell mitosis versus apoptosis by requirement
for new macromolecular synthesis. Endocrinology,
140: 2696-2703, 1999. |
| 22) |
Y. Morita, G. I. Perez,
D. V. Maravei, K. I. Tilly and J. L. Tilly: Targeted
expression of Bcl-2 in mouse oocytes prevents apoptosis.
Journal of the Society for Gynecologic Investigation
6 (Supplement), 96, 1999. |
| 23) |
Y. Morita, G. I. Perez
and J. L. Tilly: Caspases are required for germ
cell apoptosis during mouse fetal ovarian development.
Journal of the Society for Gynecologic Investigation
6 (Supplement), 95, 1999. |
| 24) |
Y. Morita, G. I. Perez,
D. V. Maravei, K. I. Tilly and J. L. Tilly: Targeted
expression of Bcl-2 in mouse oocytes inhibits ovarian
follicle atresia and prevents spontaneous and chemotherapy-induced
oocyte apoptosis in vitro. Molecular Endocrinology,
13, 841-850, 1999. |
| 25) |
Y. Morita and J. L. Tilly:
Oocyte apoptosis: like sand through an hourglass.
Developmental Biology, 213: 1-17, 1999. |
| 26) |
H. Uechi, O. Tsutsumi,
Y. Morita, Y. Takai and Y. Taketani: Comparison
of the effects of rapid and ultrarapid cryopreservation
on mouse two-cell embryos and subsequent development.
Human Reproduction, 14: 2827-2832, 1999. |
| 27) |
M. Mishima, T. Yano,
H. Jimbo, N. Yano, Y. Morita, H. Yoshikawa, A. V.
Schally and Y. Taketani: Inhibition of human endometrial
cancer cell growth in vitro and in vivo by somatostatin
analog RC-160. American Journal of Obstetrics and
Gynecology, 181: 583-590, 1999. |
| 28) |
Y. Morita and J. L. Tilly:
Sphingolipid regulation of female gonadal cell apoptosis.
Ann. N. Y. Acad. Sci., 905: 209-220, 2000. |
| 29) |
R. Robles, Y. Morita,
K. K. Mann, G. I. Perez, S. Yang, T. Matikainen,
D. H. Sherr and J. L. Tilly: The aryl hydrocarbon
receptor, a basic helix-loop-helix transciption
factor of the PAS gene family, is required for normal
ovarian germ cell dynamics in the mouse. Endocrinology,
141: 450-453, 2000. |
| 30) |
Y. Morita, F. Paris,
G. I. Perez, R. N. Kolesnick and J. L. Tilly: Protection
of the ovary from radiation-induced damage by small
molecule therapy in vivo. Journal of the Society
for Gynecologic Investigation 6 (Supplement), 164,
2000. |
| 31) |
D. V. Maravei, Y. Morita,
S. Wang, L. Bergeron, J. Yuan and J. L. Tilly: Caspase-2-deficiency
rescues female gametogenic failure resulting from
cytokine insufficiency but not meiotic defects.
Journal of the Society for Gynecologic Investigation
6 (Supplement), 92, 2000. |
| 32) |
J. L. Tilly, Y. Morita,
D. V. Maravei, T. Matikainen and G. I. Perez: Genetic
control of apoptosis in oocytes. Proceedings from
the 5th International Turner Symposium-Optimizing
Health Care for Turner Patients in the 21st Century
Naples, Italy, March, 2000. |
| 33) |
Y. Morita, O. Nishii,
M. Kido and O. Tsutsumi: Parvovirus infection after
laparoscopic hysterectomy using fibrin glue hemostasis.
Obstetrics and Gynecology, 95: 1026, 2000. |
| 34) |
Y. Takai, O. Tsutsumi,
I. Harada, Y. Morita, M. Momoeda, Y. Fukushima,
Y. Taketani: A case of XY pure gonadal dysgenesis
with 46,XYp-/47, XXYp- karyotype whose gonadoblastoma
was removed laparoscopically. Gynecologic and Obstetric
Investigation, 50: 166-169, 2000. |
| 35) |
Y. Morita, G. I. Perez,
F. Paris, S. R. Miranda, D. Ehleiter, A. Haimovitz-Friedman,
Z. Fuks, Z. Xie, J. C. Reed, E. H. Schuchman, R.
N. Kolesnick and J. L. Tilly: Oocyte apoptosis is
suppressed by disruption of the acid sphingomyelinase
gene or by sphingosine-1-phosphate therapy. Nature
Medicine, 6: 1109-1114, 2000. |
| 36) |
K. Koga, Y. Osuga, O.
Tsutsumi, R. Igarashi, M. Momoeda, T. Yano, T. Fujiwara,
Y. Takai, K. Kugu, Y. Morita and Y. Taketani: Increased
concentrations of soluble tumour necrosis factor
receptor (sTNFR) I and II in peritoneal fluid from
women with endometriosis. Molecular Human Reproduction
6: 929-933, 2000. |
| 37) |
Y. Morita, D. V. Maravei,
L. Bergeron, S. Wang, G. I. Perez, O. Tsutsumi,
Y. Taketani, M. Asano, R. Horai, S. J. Korsmeyer,
Y. Iwakura, J. Yuan and J. L. Tilly: Caspase-2-deficiency
prevents programmed germ cell death resulting from
cytokine insufficiency but not meiotic defects caused
by loss of ataxia telangiectasia-mutated (Atm) gene
function. Cell Death and Differentiation, 8: 614-620,
2001. |
| 38) |
Y. Morita, C. Kawamoto,
K. Sato, T. Nakajima, Y. Kanda and K. Shiromizu:
Severe liver injury with hematological disorders
following the injection of non-ionic contrast medium.
Acta Radiologica, 42: 342-344, 2001. |
| 39) |
Y. Morita, O. Tsutsumi
and Y. Taketani: Regulatory mechanisms of female
germ cell apoptosis during embryonic development:
a review. Endocrine Journal, 48: 289-301, 2001. |
| 40) |
T. M. Matikainen, T.
Moriyama, Y. Morita, G. I. Perez, S. J. Korsmeyer,
D. H. Sherr, and J. L. Tilly: Ligand activation
of the aromatic hydrocarbon receptor (AhR)-transcription
factor drives bax-dependent apoptosis in developing
fetal ovarian germ cells. Endocrinology, 143: 615-620,
2002. |
| 41) |
J. Xu, Y. Osuga, T. Yano,
Y. Morita, X. Tang, T. Fujiwara, Y. Takai, H. Matsumi,
K. Koga, Y. Taketani and O. Tsutsumi: Bisphenol
A induces apoptosis and G2-to-M arrest of ovarian
granulosa cells. Biochemical Biophysical Research
Communication, 292: 456-462, 2002. |
| 42) |
A. Fujimoto, Y. Osuga,
T. Fujiwara, T. Yano, O. Tsutsumi, M. Momoeda, K.
Kugu, K. Koga, Y. Morita, O. Wada and Y. Taketani:
Human chorionic gonadotropin combined with progesterone
for luteal support improves pregnancy rate in patients
with low late-midluteal estradiol levels in IVF
cycles. J Assist Reprod Genet, 19: 550-554, 2002. |
| 43) |
Y. Morita, N. Ito, H.
Hikida, S. Takeuchi, K. Nakamura, H. Ohashi: Non-invasive
magnetic resonance imaging-guided focused ultrasound
treatment for uterine fibroids - early experience.
Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):199-203.
Epub 2007 Dec 21. |
| 44) |
Y. Morita, N. Ito, H.
Ohashi: Pregnancy and birth after MR guided focused
ultrasound surgery for an a-symptomatic uterine
fibroid. International Journal of Gynecology & Obstetrics
99: 56-57, 2007. |
| 45) |
S．Fujita, Y. Morita,
H. Iwata: High-throughput evaluation of quiescent
hematopoietic progenitor cells using a micro-multiwell
plate. Anal Bioanal Chem: 391, 2753-2758, 2008. |
| 46) |
A. Okada, Y. Morita,
H. Fukunishi, K. Takeuchi and T. Murakami: Non-invasive
magnetic resonance-guided focused ultrasound treatment
of uterine fibroids in a large Japanese population:
impact of the learning curve on patient outcome.
Ultrasound Obstet Gynecol. 2009 Nov;34(5):579-83. |
| 47) |
S. Fujita, J. Toguchida,
Y. Morita, H. Iwata. Clonal analysis of hematopoiesis-supporting
activity of human mesenchymal stem cells in association
with Jagged1 expression and osteogenic potential.
Cell Transplant. 2008;17(10-11):1169-79. |
| 48) |
J. Rabinovici, M. David,
H. Fukunishi, Y. Morita, BS. Gostout, EA. Stewart:
Pregnancy outcome after magnetic resonance-guided
focused ultrasound surgery (MRgFUS) for conservative
treatment of uterine fibroids. Fertil Steril. 2008
Nov 13. [Epub ahead of print]. |
| 49) |
Y. Morita, S. Takeuchi,
H. Hikida, H. Ohashi, N. Ito: Decreasing margins
to the uterine serosa as a method for increasing
the volume of fibroids ablated with magnetic resonance-guided
focused ultrasound surgery. Eur J Obstet Gynecol
Reprod Biol. 2009 Sep;146(1):92-5. Epub 2009 May
28. |
|
|
|
| ※投稿中も含む |
|
|
|
| 和文論文 英文論文 |
|
|
|
|
|
|
